The tumor necrosis factor (TNF) superfamily member CD70 (also known as TNFSF7) has previously been identified as a biomarker and potential target for the treatment of certain malignancies.

an Armored Allogeneic Anti-CD70 γδ CAR T Cell Therapy, Demonstrates Improved Efficacy and Safety in Preclinical Models Compared to Conventional αβ CAR Benchmarks Poster/Abstract Number ...